According to Mordor Intelligence, the synthetic biology market size was valued at USD 19.75 billion in 2025 and is projected ...
As demand for synthetic peptide compounds in British academic and biotech laboratories reaches record levels, Syntech ...
The synthetic biology market is being shaped by the growing use of engineered organisms in drug development, vaccine production, and gene therapies. The ability to manipulate DNA and create customized ...
A single-dose of Trogenix’s proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated cases with no toxicity ...
A new tool makes it possible to screen millions of tiny protein fragments and select those that can be recognized by the ...
Researchers introduces an innovative chemical strategy to create biomimetic structures with greater efficiency.
Pichia pastoris (Komagataella phaffii) stands as a central organism in the field of microbial biotechnology, renowned for its robust capabilities in ...
The collaboration pairs Mimulus's molecular architecture with GenScript's massive synthesis scale to liberate critical grid power for AI compute and launch the "Forever Archive" for enterprise data ...
The EIC has announced €118 million in funding for 30 research projects under its 2025 EIC Pathfinder Challenges call ...
The Company Trying to Resurrect the Woolly Mammoth Already Brought Back the Dire Wolf. The Real Story Is What It Built Along ...
Tema Oncology ETF gets a Hold rating amid inconsistent returns. Click here for my look at CANC, its top holdings, and an alternative fund.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results